Common Side Effects and Metabolic Syndrome due to Clozapine: Relationship with the Clinical Variables and Disability

Gurcan G., Senol S. H., ANIL YAĞCIOĞLU A. E., KARAHAN S., ERTUĞRUL A.

TURK PSIKIYATRI DERGISI, cilt.32, sa.2, ss.87-99, 2021 (SSCI) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 2
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5080/u25737
  • Dergi Adı: TURK PSIKIYATRI DERGISI
  • Derginin Tarandığı İndeksler: Social Sciences Citation Index (SSCI), Scopus, Central & Eastern European Academic Source (CEEAS), EMBASE, MEDLINE, Psycinfo, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.87-99
  • Anahtar Kelimeler: clozapine, schizophrenia, side effect, metabolic syndrome, 2ND-GENERATION ANTIPSYCHOTICS, ATYPICAL ANTIPSYCHOTICS, INDUCED HYPERSALIVATION, WEIGHT-GAIN, SCHIZOPHRENIA, PREVALENCE, SCALE, TOLERABILITY, SAFETY, MANAGEMENT
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Common side effects due to clozapine may affect the treatment process negatively. In this study, we aimed to assess the common side effects and the prevalence of metabolic syndrome in schizophrenia patients treated with clozapine, and to study their relationship with clinical variables and disability.